Evidence map›Paper›PMID 20678503›Full record

ReviewJournal of molecular biology2010

The miR-15/107 group of microRNA genes: evolutionary biology, cellular functions, and roles in human diseases.

John R Finnerty, Wang-Xia Wang, Sébastien S Hébert, Bernard R Wilfred, Guogen Mao, Peter T Nelson

Open access · greenAbstract readReview
In one paragraph

Review in Journal of molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 217 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
217citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

217 citing papers in PubMed, 2 syntheses or guidelines pooled it, 375 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. MicroRNAs in metabolism for precision treatment of lung cancer.Cellular & molecular biology letters · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

157 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

John R FinnertyDivision of Neuropathology, Department of Pathology, University of Kentucky Medical Center and Sanders-BrownCenter on Aging, University of Kentucky, Lexington, KY 40536, USA.
Wang-Xia Wang
Sébastien S Hébert
Bernard R Wilfred
Guogen Mao
Peter T Nelson
Boston University · USUniversity of Kentucky · US

Funding

University of Kentucky Alzheimer's Disease Core Center - Biomarker CoreP30AG028383 · NIA · UNIVERSITY OF KENTUCKY · PI GOLD, BRIAN TIMOTHY, VAN ELDIK, LINDA J · 2006 to 2020
$23.3M
A specific microRNA (Mir-107) is a potential therapeutic target in Alzheimer's diR01NS061933 · NINDS · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2008 to 2011
$1.3M
Alpha-synuclein mRNA is a putative microRNA targetK08NS050110 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI NELSON, PETER T. · 2005 to 2009
$863k
Novel assay identifies all microRNA targets in Alzheimer and normal aged brainsR21AG036875 · NIA · UNIVERSITY OF KENTUCKY · PI NELSON, PETER T. · 2010 to 2011
$341k
NIA NIH HHS P30 AG028383NIA NIH HHS P30-AG028383NIA NIH HHS R21 AG036875NINDS NIH HHS K08 NS050110NINDS NIH HHS R01 NS061933
6 · The paper itself

Abstract

The miR-15/107 group of microRNA (miRNA) gene is increasingly appreciated to serve key functions in humans. These miRNAs regulate gene expression involved in cell division, metabolism, stress response, and angiogenesis in vertebrate species. The miR-15/107 group has also been implicated in human cancers, cardiovascular disease and neurodegenerative disease, including Alzheimer's disease. Here we provide an overview of the following: (1) the evolution of miR-15/107 group member genes; (2) the expression levels of miRNAs in mammalian tissues; (3) evidence for overlapping gene-regulatory functions by different miRNAs; (4) the normal biochemical pathways regulated by miR-15/107 group miRNAs; and (5) the roles played by these miRNAs in human diseases. Membership in this group is defined based on sequence similarity near the mature miRNAs' 5' end: all include the sequence AGCAGC. Phylogeny of this group of miRNAs is incomplete; thus, a definitive taxonomic classification (e.g., designation as a "superfamily") is currently not possible. While all vertebrates studied to date express miR-15a, miR-15b, miR-16, miR-103, and miR-107, mammals alone are known to express miR-195, miR-424, miR-497, miR-503, and miR-646. Multiple different miRNAs in the miR-15/107 group are expressed at moderate to high levels in human tissues. We present data on the expression of all known miR-15/107 group members in human cerebral cortical gray matter and white matter using new miRNA profiling microarrays. There is extensive overlap in the mRNAs targeted by miR-15/107 group members. We show new data from cultured H4 cancer cells that demonstrate similarities in mRNAs targeted by miR-16 and miR-103 and also support the importance of the mature miRNAs' 5' seed region in mRNA target recognition. In conclusion, the miR-15/107 group of miRNA genes is a fascinating topic of study for evolutionary biologists, miRNA biochemists, and clinically oriented translational researchers alike.

Indexed as

Gene Expression RegulationMicroRNAsAnimalsCell ProliferationCerebral CortexEvolution, MolecularHeart DiseasesHumansNeoplasmsNeovascularization, PathologicNeovascularization, PhysiologicNeurodegenerative DiseasesOligonucleotide Array Sequence AnalysisMicroRNAs

Identifiers

PMID20678503
PMCPMC2978331
OpenAlexW1969955808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.